# EDGAR Filing Document

**Accession Number:** 0000851205
**File Stem:** 0001157523-23-000296
**Filing Date:** 2023-2
**Character Count:** 44542
**Document Hash:** 7608b6713b63ead2130f1edbf2028550
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001157523-23-000296.hdr.sgml**: 20230216

**ACCESSION NUMBER**: 0001157523-23-000296

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230215

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230216

**DATE AS OF CHANGE**: 20230216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** COGNEX CORP
- **CENTRAL INDEX KEY:** 0000851205
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
- **IRS NUMBER:** 042713778
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34218
- **FILM NUMBER:** 23638574

**BUSINESS ADDRESS:**
- **STREET 1:** ONE VISION DR
- **CITY:** NATICK
- **STATE:** MA
- **ZIP:** 01760
- **BUSINESS PHONE:** 5086503000

**MAIL ADDRESS:**
- **STREET 1:** ONE VISION DRIVE
- **CITY:** NATICK
- **STATE:** MA
- **ZIP:** 01760

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, DC 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 15, 2023

<u> Cognex Corporation </u> <br> (Exact name of registrant as specified in charter)

<u>Massachusetts </u> <u>001-34218 </u> <u>04-2713778 </u> <br> (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

<u> One Vision Drive, Natick, Massachusetts </u> <u> 01760-2059 </u> <br> (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (508) 650-3000

<u>N/A </u> <br> (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class**  | **Trading Symbol(s)**  | **Name of each exchange on which registered**  |
| Common Stock, par value $.002 per share | CGNX | The NASDAQ Stock Market LLC |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 2.02** <br>| **Results of Operations and Financial Condition** <br>|

---

On February 16, 2023, Cognex Corporation (the "Company") issued a news release to report its financial results for the quarter and year ended December 31, 2022. The release is furnished as Exhibit 99.1 hereto. The information in Item 2.02 of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.

---

| | |
|:---|:---|
| **Item 5.02** <br>| **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers** <br>|

---

On February 15, 2023, the Board of Directors (the "Board") of the Company authorized an increase to the number of directors on the Board from eight to nine and appointed Angelos Papadimitriou as a director of the Company. The Board appointed Mr. Papadimitriou, effective February 17, 2023, to serve in accordance with the bylaws of the Company and until his successor is duly elected and qualified. Mr. Papadimitriou shall serve on the Audit Committee of the Board of Directors. At the Company's 2023 Annual Meeting of Shareholders, the Board will nominate Mr. Papadimitriou for election to the class of directors whose term ends in 2026. A copy of the press release announcing Mr. Papadimitriou's appointment is attached hereto as Exhibit 99.2 and is hereby incorporated by reference.

Mr. Papadimitriou, age 56, currently serves as Chairman of the Board of Directors of Athena Ventures, an early-stage venture fund. From August 2020 to February 2021, Mr. Papadimitriou was the Co-Chief Executive Officer of Pirelli & C. S.p.A., a public company listed on the Milan Stock Exchange. Mr. Papadimitriou previously led Coesia S.p.A., a group of global industrial and packaging solutions companies as their Chief Executive Officer for ten years. Mr. Papadimitriou currently serves as a director of Humanitas, a privately held network of teaching and research hospitals and Dompé Farmaceutici S.p.A., a privately-held biopharmaceutical company. Mr. Papadimitriou holds an MBA from the Harvard Graduate School of Business Administration and a Bachelor of Arts in Computer Science and Business Economics from Brown University.

Mr. Papadimitriou's qualifications for sitting on the Board include his executive leadership experience, including his service as chief executive officer of a large public company, perspective from his service on other company boards and expertise in the packaging machinery and industrial automation industries and European and international markets.

For his service on the Board, Mr. Papadimitriou will receive an annual stipend of $50,000, and for his service on the Audit Committee, Mr. Papadimitriou will receive an additional annual stipend of $10,000. Further, subject to Board approval, Mr. Papadimitriou will receive annual equity awards under the Company's 2007 Stock Option and Incentive Plan (the "2007 Plan") consistent with the Company's other non-employee Board members. Mr. Papadimitriou will receive an initial equity award under the 2007 Plan of restricted stock units ("RSUs") having an economic value of approximately $240,000 on the date of grant. These RSUs will vest over three years: 20% on the first anniversary of the grant date; 30% on the second anniversary; and 50% on the third anniversary. Mr. Papadimitriou will enter into the Company's standard indemnification agreement, which has been previously entered into with each of the Company's directors, and the form of which has been filed by the Company with the SEC.

There is no arrangement or understanding between Mr. Papadimitriou and any other person pursuant to which he was selected as a director, nor is the Company aware, after inquiry of Mr. Papadimitriou, of any related-person transaction or series of transactions required to be disclosed pursuant to Item 404(a) of Regulation S-K.

In addition, on February 15, 2023, Directors Theodor Krantz and Patrick Alias each informed the Company of his decision to retire from the Company's Board, effective May 3, 2023, upon completion of his current term as a director. Mr. Alias will remain as an employee of the Company in an advisory role. Following the departures of Mr. Krantz and Mr. Alias, the number of directors on the Board will be decreased from nine to seven.

---

| | |
|:---|:---|
| **Item 8.01** <br>| **Other Events**  |

---

On February 16, 2023, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.07 per share. The dividend is payable on March 17, 2023, to all shareholders of record at the close of business on March 3, 2023.

---

| | |
|:---|:---|
| **Item 9.01** <br>| **Financial Statements and Exhibits**  |

---

(d) Exhibits

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| [99.1](a53329327ex99_1.htm)  | [News release, dated February 16, 2023, by Cognex Corporation with respect to financial results for the quarter and year ended December 31, 2022 (furnished herewith)](a53329327ex99_1.htm) |
| [99.2](a53329327ex99_2.htm)  | [News release, dated February 16, 2023, by Cognex Corporation announcing the appointment of Angelos Papadimitriou to the Board of Directors](a53329327ex99_2.htm)  |
| 104  | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document) |

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | COGNEX CORPORATION <br>|
| Dated: February 16, 2023 <br>| <u>By:/s/ Paul Todgham</u> <br>|
|  | Paul Todgham <br>|
|  | Senior Vice President and Chief Financial Officer <br>|

---

## Exhibit 99.1

**Exhibit 99.1**<br>

**** 

<br> **** 

<br> # **Cognex Reports Fourth Quarter and Full Year 2022 Results** 
NATICK, Mass.--(BUSINESS WIRE)--February 16, 2023--Cognex Corporation (NASDAQ: CGNX) today reported financial results for 2022. Table 1 below shows selected financial data for Q4-22 compared with Q4-21 and Q3-22, and the year ended December 31, 2022 compared with the year ended December 31, 2021.

"Our fourth quarter results were in line with our guidance, but are not representative of our long-term growth expectations," said Robert J. Willett, CEO of Cognex. "We are navigating through a challenging business environment. A few of our largest e-commerce customers have paused most of their investments. At the end of 2022, we observed slower trends across our broader factory automation business, and we have seen this carry into the beginning of 2023."

"As we manage through this slow period, we remain focused on the long term. We have important new product launches coming up this year. These products bring powerful, easy-to-use technology which expands the number of customers we can serve. And we are investing in our sales and marketing organization to reach more of these emerging customers."

 **<u>Table 1</u>** <br> (Dollars in thousands, except per share amounts)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | <br>**<u>Revenue</u>**  | <br>**<u>Net Income</u>**  | <br> **Net Income** <br> **per Diluted** <br> **<u>Share</u>**  | **Non-GAAP** <br> **Net Income** <br> **per Diluted** <br> **<u>Share\*</u>**  |
| **<u>Quarterly Comparisons</u>**  |  |  |  |  |
| **Current quarter: Q4-22**  | **$239433**  | **$55311**  | **$0.32**  | **$0.27**  |
| Prior year's quarter: Q4-21  | $244065  | $53535  | $0.30  | $0.30  |
| Change: Q4-21 to Q4-22  | (2)%  | 3%  | 7%  | (10)%  |
| Prior quarter: Q3-22  | $209622  | $33980  | $0.19  | $0.21  |
| Change: Q3-22 to Q4-22  | 14%  | 63%  | 68%  | 29%  |
| **<u>Yearly Comparisons</u>**  |  |  |  |  |
| **Year ended December 31, 2022**  | **$1006090**  | **$215525**  | **$1.23**  | **$1.31**  |
| Year ended December 31, 2021  | $1037098  | $279881  | $1.56  | $1.49  |
| Change from 2021 to 2022  | (3)%  | (23)%  | (21)%  | (12)%  |
| <br> \*Non-GAAP net income per diluted share excludes a loss from fire and restructuring charges, both net of tax benefit, and discrete tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.  | <br> \*Non-GAAP net income per diluted share excludes a loss from fire and restructuring charges, both net of tax benefit, and discrete tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.  | <br> \*Non-GAAP net income per diluted share excludes a loss from fire and restructuring charges, both net of tax benefit, and discrete tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.  | <br> \*Non-GAAP net income per diluted share excludes a loss from fire and restructuring charges, both net of tax benefit, and discrete tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.  | <br> \*Non-GAAP net income per diluted share excludes a loss from fire and restructuring charges, both net of tax benefit, and discrete tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.  |

---

------

 **<u>Summary of the Year</u>**

As a result of our challenges in 2022, annual revenue declined by 3% from a record $1.037 billion in 2021. With approximately 60% of our revenue outside the Americas, the strong U.S. dollar was a headwind for us in the year. Excluding the impact of foreign currency translation, our revenue grew 1%. Outside of our logistics business, our performance in 2022 was roughly in**-**line on a constant currency basis with what we would expect over the long term for the remainder of our end markets.

Gross margin was 72% compared to 73% for 2021 and below the company's mid-70% long-term target. The decline was due to elevated costs paid by Cognex to purchase scarce components because of global supply chain constraints and to replace the components lost in the fire at the company's primary contract manufacturer in June 2022.

Operating income was 24% of revenue compared to 30% for 2021. Cognex recorded a pre-tax net loss of $20.8 million from the write-off of company assets that were destroyed or abandoned in the fire, lower annual revenue, and continued to invest in engineering and its worldwide sales force to help scale for future growth. The company also recorded pre-tax restructuring charges of $1.7 million related to the acquisition of SAC Sirius Advanced Cybernetics GmbH ("SAC") in the fourth quarter.

 **<u>Details of the Quarter</u>**

 **Statement of Operations Highlights – Fourth Quarter of 2022**

* Revenue decreased by 2% from Q4-21 and increased by 14% from Q3-22, or increased by 4% and 17%, respectively, in constant currency. The increase in constant currency, both year-on-year and sequentially, was largely driven by the
 recognition of approximately $20 million of revenue in the quarter that was delayed from the third quarter due to business disruption caused by the June fire. Otherwise, slowing large projects with a few e-commerce customers reduced revenue
 year-on-year, partially offset by growth in our other end markets. 

* Gross margin was 71% for Q4-22 compared to 72% for Q4-21 and 73% for Q3-22. The premiums paid by Cognex to quickly replace components through brokers following the fire reduced gross margin in the quarter, but had a minimal impact
 year-on-year. The unfavorable impact of currency exchange rates on revenue also reduced gross margin year-on-year. 

* Research, Development, & Engineering (RD&E) expenses increased by 5% from Q4-21 and 9% from Q3-22. The company has invested in engineering resources over the past year and stock-based compensation was higher in Q4 on both a
 year-on-year and sequential basis. These increases were partially offset by a favorable impact of currency exchange rates in Q4-22 as compared to both Q4-21 and Q3-22. 

* Selling, General & Administrative (SG&A) expenses decreased by 8% from Q4-21 and increased by 1% from Q3-22. The expansion of the company's global sales and marketing organization was offset by lower incentive compensation and the
 timing of marketing activities. In addition, as with RD&E, Cognex benefitted from a favorable impact of currency exchange rates in Q4-22 as compared to both Q4-21 and Q3-22. 

* Cognex recorded pre-tax charges of $0.5 million and $2.9 million in Q4-22 and Q3-22, respectively, related to the June 2022 fire at the company's primary contract manufacturer. In addition, the company recorded pre-tax charges of $1.7
 million in Q4-22 related to the previously announced acquisition of SAC, a leading computational lighting company. 

* The effective tax rate was 7% in Q4-22, 8% in Q4-21, and 14% in Q3-22. All periods presented include varying tax adjustments, which are summarized in Exhibit 2. Excluding these tax adjustments, the effective tax rate was 22% in Q4-22, 8%
 in Q4-21, and 14% in Q3-22. 

------

 **Balance Sheet Highlights – December 31, 2022**

* Cognex's financial position as of December 31, 2022 continued to be strong, with $854 million in cash and investments and no debt (following significant cash outflows to replenish inventory destroyed in the June fire). In 2022,
 Cognex generated $243 million in cash from operations. During the year, the company spent $204 million to repurchase its common stock and paid $46 million in dividends to shareholders. Cognex intends to continue to repurchase shares of its
 common stock pursuant to its existing stock repurchase program, subject to market conditions and other relevant factors. 

 **Financial Outlook – Q1 2023**

* Cognex expects revenue for Q1-23 to be between $180 million and $200 million. This range represents a decline both year-on-year and sequentially due to lower revenue from a few large e-commerce customers and broader macroeconomic softness.
 As a reminder, both Q1-22 and Q4-22 included $20 million of revenue for orders that had been delayed due to supply constraints, including with respect to the June fire. 

* Gross margin for Q1-23 is expected to be in the low-70% range and reflects the significant premiums the company has paid to procure components previously destroyed by the fire. 

* The combined total of expenses for RD&E and SG&A is expected to increase by approximately 10% on a sequential basis due to investments in the company's sales and marketing organization, merit increases, and an unfavorable impact
 from currency exchange rates. 

* The effective tax rate is expected to be 16%, excluding discrete tax items. 

 **Non-GAAP Financial Measures**

* Exhibit 2 of this news release includes a reconciliation of certain financial measures from GAAP to non-GAAP. Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare results
 over multiple periods using the same methodology that management employs in its budgeting process and in its review of operating results. Non-GAAP presentations exclude certain one-time discrete events, such as a fire loss, restructuring
 charges, and tax adjustments (because these costs are outside of Cognex's normal business operations and not used by management to assess Cognex's operating results). Cognex also uses results on a constant-currency basis as one measure to
 evaluate its performance and compares results between periods as if the exchange rates had remained constant period-over-period. Cognex does not intend for non-GAAP financial measures to be considered in isolation, or as a substitute for
 financial information provided in accordance with GAAP. 

* We estimate the tax effect of items identified in the reconciliation by applying the effective tax rate to the pre-tax amount. However, if a specific tax rate or tax treatment is required because of the nature of the item and/or the tax
 jurisdiction where the item was recorded, we estimate the tax effect by applying the relevant specific tax rate or tax treatment, rather than the effective tax rate. 

 **Analyst Conference Call and Simultaneous Webcast**

* Cognex will host a conference call today at 5:00 p.m. Eastern Standard Time (EST). The telephone number is (877) 704-4573 (or (201) 389-0911 if outside the United States). A replay will begin at 8:00 p.m. EST today and will be available
 until 11:59 p.m. EST on Sunday, February 19, 2023. The telephone number for the replay is (877) 660-6853 (or (201) 612-7415 if outside the United States). The access code for both the live call and the replay is 1373 4893. 

* A real-time audio broadcast of the conference call or an archived recording will be accessible on the Events & Presentations page of the Cognex Investor website: https://www.cognex.com/Investor. 

------

 **About Cognex Corporation**

Cognex Corporation ("the Company" or "Cognex") invents and commercializes technologies that address some of the most critical manufacturing and distribution challenges. We are a leading global provider of machine vision products and solutions that improve efficiency and quality in high-growth-potential businesses across attractive industrial end markets. Our solutions blend physical products and software to capture and analyze visual information, allowing for the automation of manufacturing and distribution tasks for customers worldwide. Machine vision products are used to automate the manufacturing or distribution and tracking of discrete items, such as mobile phones, electric vehicle batteries and e-commerce packages, by locating, identifying, inspecting, and measuring them. Machine vision is important for applications in which human vision is inadequate to meet requirements for size, accuracy, or speed, or in instances where substantial cost savings or quality improvements are maintained.

Cognex is the world's leader in the machine vision industry, having shipped more than 4 million image-based products, representing over $10 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

 *Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words "expects," "anticipates," "estimates," "potential," "believes," "projects," "intends," "plans," "will," "may," "shall," "could," "should," and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance and financial targets, the expected impact of the fire at our primary contract manufacturer's plant on our assets, business and results of operations and related insurance recoveries, customer demand and order rates and timing of related revenue, managing supply shortages, delivery lead times, future product mix, research and development activities, sales and marketing activities, new product offerings and product development activities, capital expenditures, investments, liquidity, dividends and stock repurchases, strategic and growth plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the reliance on key suppliers, such as our primary contract manufacturer, to manufacture and deliver products; (2) the expected impact of the fire at our primary contract manufacturer's plant on our assets, business, and results of operations and related insurance recoveries; (3) delays in the delivery of our products, the failure to meet delivery schedules, and resulting customer dissatisfaction or loss of sales; (4) the inability to obtain, or the delay in obtaining, components for our products at reasonable prices; (5) the failure to effectively manage product transitions or accurately forecast customer demand; (6) the inability to manage disruptions to our distribution centers or to our key suppliers; (7) the inability to design and manufacture high-quality products; (8) the impact, duration, and severity of the COVID-19 pandemic, particularly in China, including the availability and effectiveness of vaccines as well as government lockdowns; (9) the loss of, or curtailment of purchases by, large customers in the logistics, consumer electronics, or automotive industries; (10) information security breaches; (11) the failure to comply with laws or regulations relating to data privacy or data protection; (12) the inability to protect our proprietary technology and intellectual property; (13) the inability to attract and retain skilled employees and maintain our unique corporate culture; (14) the technological obsolescence of current products and the inability to develop new products; (15) the failure to properly manage the distribution of products and services, including the management of lead times and delivery dates; (16) the impact of competitive pressures; (17) the challenges in integrating and achieving expected results from acquired businesses; (18) potential disruptions in our business systems; (19) potential impairment charges with respect to our investments or acquired intangible assets; (20) exposure to additional tax liabilities, increases and fluctuations in our effective tax rate, and other tax matters; (21) fluctuations in foreign currency exchange rates and the use of derivative instruments; (22) unfavorable global economic conditions, including increases in interest rates and high inflation rates; (23) business disruptions from natural or man-made disasters, such as fire, or public health issues; (24) economic, political, and other risks associated with international sales and operations, including the impact of trade disputes on the economic climate in China and the war in Ukraine; (25) exposure to potential liabilities, increased costs, reputational harm, and other adverse effects associated with expectations relating to environmental, social, and governance considerations; (26) stock price volatility; and (27) our involvement in time-consuming and costly litigation or activist shareholder activities; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2022. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.*

------

 <u>**Exhibit 1**</u>

 **COGNEX CORPORATION <br> Statements of Operations <br> (Unaudited) <br> Dollars in thousands, except per share amounts**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three-months Ended**  | **Three-months Ended**  | **Three-months Ended**  | **Twelve-months Ended**  | **Twelve-months Ended**  |
|  | **Dec. 31,** <br> **2022**  | Oct. 2, <br> 2022  | Dec. 31, <br> 2021  | **Dec. 31,** <br> **2022**  | Dec. 31, <br> 2021  |
| Revenue  | $**239433**  | $209622  | $244065  | $**1006090**  | $1037098  |
| Cost of revenue (1)  | **69869**  | 57383  | 69082  | **284185**  | 277271  |
| Gross margin  | **169564**  | 152239  | 174983  | **721905**  | 759827  |
| &nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue*  | ***71*** <br> *%***  | *73* <br> *%*  | *72* <br> *%*  | ***72*** <br> *%***  | *73* <br> *%*  |
| Research, development, and engineering expenses (1)  | **37134**  | 33954  | 35489  | **141133**  | 135372  |
| &nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue*  | ***16*** <br> *%***  | *16* <br> *%*  | *15* <br> *%*  | ***14*** <br> *%***  | *13* <br> *%*  |
| Selling, general, and administrative expenses (1)  | **75951**  | 75371  | 82974  | **312107**  | 309354  |
| &nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue*  | ***32*** <br> *%***  | *36* <br> *%*  | *34* <br> *%*  | ***31*** <br> *%***  | *30* <br> *%*  |
| Restructuring charges  | **1657**  | —  | —  | **1657**  | —  |
| Loss from fire  | **485**  | 2891  | —  | **20779**  | —  |
| Operating income  | **54337**  | 40023  | 56520  | **246229**  | 315101  |
| &nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue*  | ***23*** <br> *%***  | *19* <br> *%*  | *23* <br> *%*  | ***24*** <br> *%***  | *30* <br> *%*  |
| Foreign currency gain (loss)  | **2530**  | (1880 ) | (37 ) | **(1837)** <br>  | (2270 ) |
| Investment and other income  | **2364**  | 1202  | 1464  | **6303**  | 6069  |
| Income before income tax expense  | **59231**  | 39345  | 57947  | **250695**  | 318900  |
| Income tax expense  | **3920**  | 5365  | 4412  | **35170**  | 39019  |
| Net income  | $**55311**  | $33980  | $53535  | $**215525**  | $279881  |
| &nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue*  | ***23*** <br> *%***  | *16* <br> *%*  | *22* <br> *%*  | ***21*** <br> *%***  | *27* <br> *%*  |
| Net income per weighted-average common and common-equivalent share:  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic  | $**0.32**  | $0.20  | $0.30  | $**1.24**  | $1.59  |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted  | $**0.32**  | $0.19  | $0.30  | $**1.23**  | $1.56  |
| Weighted-average common and common-equivalent shares outstanding:  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic  | **172693**  | 173256  | 176123  | **173407**  | 176463  |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted  | **173903**  | 174327  | 179322  | **174869**  | 179916  |
| Cash dividends per common share  | $**0.070**  | $0.065  | $0.065  | $**0.265**  | $0.245  |
| Cash and investments per common share  | $**4.95**  | $4.73  | $5.17  | $**4.95**  | $5.17  |
| Book value per common share  | $**8.33**  | $8.03  | $8.15  | $**8.33**  | $8.15  |
| (1) Amounts include stock-based compensation expense, as follows:  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cost of revenue  | $**503**  | $468  | $380  | $**2016**  | $1345  |
| &nbsp;&nbsp;&nbsp;&nbsp; Research, development, and engineering  | **5185**  | 4209  | 3377  | **17693**  | 13535  |
| &nbsp;&nbsp;&nbsp;&nbsp; Selling, general, and administrative  | **7398**  | 8689  | 6664  | **34796**  | 28894  |
| &nbsp;&nbsp;&nbsp;&nbsp; Total stock-based compensation expense  | $**13086**  | $13366  | $10421  | $**54505**  | $43774  |

---

------

 **<u>Exhibit 2</u>**

 **COGNEX CORPORATION <br> Reconciliation of Selected Items from GAAP to Non-GAAP <br> (Unaudited) <br> Dollars in thousands, except per share amounts**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three-months Ended**  | **Three-months Ended**  | **Three-months Ended**  | **Twelve-months Ended**  | **Twelve-months Ended**  |
|  | **Dec. 31,** <br> **2022**  | Oct. 2, <br> 2022  | Dec. 31, <br> 2021  | **Dec. 31,** <br> **2022**  | Dec. 31, <br> 2021  |
| **Per share impact of restructuring charges and loss from fire**  | **Per share impact of restructuring charges and loss from fire**  | **Per share impact of restructuring charges and loss from fire**  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring charges  | $**1657**  | $—  | $—  | $**1657**  | $—  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tax benefit from restructuring charges  | **(523)** <br>  | —  | —  | **(523)** <br>  | —  |
| &nbsp;&nbsp; Restructuring charges, net of tax benefit  | $**1134**  | $—  | $—  | $**1134**  | $—  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Per share impact of restructuring charges, net of tax benefit  | $**0.01**  | $—  | $—  | $**0.01**  | $—  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss from fire  | $**485**  | $2891  | $—  | $**20779**  | $—  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tax benefit from loss on fire  | **(278)** <br>  | (928 )  | —  | **(3646)** <br>  | —  |
| &nbsp;&nbsp; Loss from fire, net of tax benefit  | $**207**  | $1963  | $—  | $**17133**  | $—  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Per share impact of loss from fire, net of tax benefit  | **—**  | 0.01  | —  | **0.10**  | —  |
| &nbsp;&nbsp; Diluted weighted-average common and common-equivalent shares outstanding (GAAP)  | **173903**  | 174327  | 179322  | **174869**  | 179916  |
| **Restructuring charges, loss from fire, and discrete tax adjustments reconciliation**  | **Restructuring charges, loss from fire, and discrete tax adjustments reconciliation**  | **Restructuring charges, loss from fire, and discrete tax adjustments reconciliation**  | **Restructuring charges, loss from fire, and discrete tax adjustments reconciliation**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating income (GAAP)  | $**54337**  | $40023  | $56520  | $**246229**  | $315101  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue (GAAP)*  | ***23*** <br> *%***  | *19* <br> *%*  | *23* <br> *%*  | ***24*** <br> *%***  | *30* <br> *%*  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring charges  | **1657**  | —  | —  | **1657**  | —  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss from fire  | **485**  | 2891  | —  | **20779**  | —  |
| &nbsp;&nbsp; Operating income (Non-GAAP)  | $**56479**  | $42914  | $56520  | $**268665**  | $315101  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue (Non-GAAP)*  | ***24*** <br> *%***  | *20* <br> *%*  | *23* <br> *%*  | ***27*** <br> *%***  | *30* <br> *%*  |
| &nbsp;&nbsp; Net income (GAAP)  | $**55311**  | $33980  | $53535  | $**215525**  | $279881  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring charges, net of tax benefit  | **1134**  | —  | —  | **1134**  | —  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss from fire, net of tax benefit  | **207**  | 1963  | —  | **17133**  | —  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discrete tax (benefit) expense related to stock-based compensation  | **(1148)** <br>  | 131  | (1148 ) | **(841)** <br>  | (11036 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discrete tax (benefit) expense related to tax return filings and other  | **(7710)** <br>  | (133 )  | 1173  | **(4033)** <br>  | (1304 )  |
| &nbsp;&nbsp; Net income (Non-GAAP)  | $**47794**  | $35941  | $53560  | $**228918**  | $267541  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Percentage of revenue (Non-GAAP)*  | ***20*** <br> *%***  | *17* <br> *%*  | *22* <br> *%*  | ***23*** <br> *%***  | *26* <br> *%*  |
| &nbsp;&nbsp; Net income per diluted weighted-average common and common-equivalent share (GAAP)  | $**0.32**  | $0.19  | $0.30  | $**1.23**  | $1.56  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Per share impact of Non-GAAP adjustments identified above  | **(0.05)** <br>  | 0.02  | —  | **0.08**  | (0.07 )  |
| &nbsp;&nbsp; Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)  | $**0.27**  | $0.21  | $0.30  | $**1.31**  | $1.49  |
| &nbsp;&nbsp; Diluted weighted-average common and common-equivalent shares outstanding (GAAP)  | **173903**  | 174327  | 179322  | **174869**  | 179916  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three-months Ended**  | **Three-months Ended**  | **Three-months Ended**  | **Twelve-months Ended**  | **Twelve-months Ended**  |
|  | **Dec. 31,** <br> **2022**  | Oct. 2, <br> 2022  | Dec. 31, <br> 2021  | **Dec. 31,** <br> **2022**  | Dec. 31, <br> 2021  |
| **Effective tax rate reconciliation**  | **Effective tax rate reconciliation**  | **Effective tax rate reconciliation**  |  |  |  |
| &nbsp;&nbsp; Income before income tax expense (GAAP)  | $**59231**  | $39345  | $57947  | $**250695**  | $318900  |
| &nbsp;&nbsp; Income tax expense (GAAP)  | $**3920**  | $5365  | $4412  | $**35170**  | $39019  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Effective tax rate (GAAP)*  | ***7*** <br> *%***  | *14* <br> *%*  | *8* <br> *%*  | ***14*** <br> *%***  | *12* <br> *%*  |
| &nbsp;&nbsp; Tax adjustments:  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discrete tax benefit (expense) related to stock-based compensation  | **1148**  | (131 ) | 1148  | **841**  | 11036  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discrete tax benefit (expense) related to tax return filings and other  | **7710**  | 133  | (1173 )  | **4033**  | 1304  |
| &nbsp;&nbsp; Total tax adjustments  | $**8858**  | $2  | $(25 ) | $**4874**  | $12340  |
| &nbsp;&nbsp; Income tax expense (Non-GAAP) (1)  | $**12778**  | $5367  | $4387  | $**40044**  | $51359  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Effective tax rate (Non-GAAP) (1)*  | ***22*** <br> *%***  | *14* <br> *%*  | *8* <br> *%*  | ***16*** <br> *%***  | *16* <br> *%*  |

---

(1) The loss from the fire in the second and third quarters of 2022 had a tax benefit that during the quarter we accounted for as a discrete tax item. At year end, we reclassified these benefits for Non-GAAP presentation purposes, and as such we have adjusted our Non-GAAP effective tax rates for the quarters impacted by the fire loss. We previously reported a 16% Non-GAAP effective tax rate for both Q2 and Q3 and Income tax expense (Non-GAAP) of $10,306 and $6,295, respectively. Using the updated classification, these rates would have been 12% and 14% and the Income tax expense (Non-GAAP) would have been $7,866 and $5,367 in Q2 and Q3, respectively. There have been no changes to any previously reported GAAP figures.

------

 **<u>Exhibit 3</u>**

 **COGNEX CORPORATION <br> Balance Sheets <br> (Unaudited) <br> Dollars in thousands**

---

| | | |
|:---|:---|:---|
|  | **December 31, 2022**  | December 31, 2021  |
| **Assets**  |  |  |
| Cash and investments  | $**854250**  | $907364  |
| Accounts receivable  | **125417**  | 130348  |
| Inventories  | **122480**  | 113102  |
| Property, plant, and equipment  | **79714**  | 77546  |
| Operating lease assets  | **37682**  | 23157  |
| Goodwill and intangible assets  | **255044**  | 253601  |
| Deferred tax assets  | **407241**  | 418570  |
| Other assets  | **76312**  | 79974  |
| Total assets  | $**1958140**  | $2003662  |
| **Liabilities and Shareholders' Equity**  |  |  |
| Accounts payable and accrued expenses  | $**120338**  | $136483  |
| Deferred revenue and customer deposits  | **40787**  | 35743  |
| Operating lease liabilities  | **39752**  | 25581  |
| Income taxes  | **67003**  | 66517  |
| Deferred tax liabilities  | **249961**  | 293769  |
| Other liabilities  | **1905**  | 15476  |
| Shareholders' equity  | **1438394**  | 1430093  |
| Total liabilities and shareholders' equity  | $**1958140**  | $2003662  |

---

## Contacts
Nathan McCurren <br> Head of Investor Relations <br> +1 508-654-1755 <br> Nathan.McCurren@cognex.com

## Exhibit 99.2

**Exhibit 99.2**<br>

**** 

<br> # **Cognex Announces Appointment of New Board Member and Retirement of Two Board Members** 
NATICK, Mass.--(BUSINESS WIRE)--February 16, 2023--Cognex Corporation (NASDAQ: CGNX) today announced the appointment of Angelos Papadimitriou to Cognex's Board of Directors, effective on February 17, 2023. Papadimitriou will serve on the Audit Committee.

"We are excited for Angelos to join our board," said Anthony Sun, Chairman of Cognex. "His executive leadership experience, expertise in packaging machinery and industrial automation industries and European and international markets, and experience as an institutional investor will be a valuable asset to Cognex. We look forward to his insight and guidance."

In addition, on February 15, 2023, Directors Theodor Krantz and Patrick Alias each informed the Company of his decision to retire from the Company's Board of Directors, effective May 3, 2023 upon completion of his current term as a director. Mr. Alias will remain as an employee of the Company in an advisory role. Following the departures of Mr. Krantz and Mr. Alias, the number of directors on the Board will be decreased from nine to seven.

 **About Angelos Papadimitriou**

Angelos Papadimitriou, 56, currently serves as Chairman of the Board of Directors of Athena Ventures, an early-stage venture fund. From August 2020 to February 2021, Mr. Papadimitriou was the Co-Chief Executive Officer of Pirelli & C. S.p.A., a public company listed on the Milan Stock Exchange. Mr. Papadimitriou previously led Coesia S.p.A., a group of global industrial and packaging solutions companies as their Chief Executive Officer for ten years. Prior to that, Mr. Papadimitriou spent over fifteen years in the pharmaceutical industry, including as Senior Vice President for Italy and Southeast Europe at Glaxosmithkline. Mr. Papadimitriou currently serves as a director of Humanitas, a privately-held network of teaching and research hospitals and Dompé Farmaceutici S.p.A., a privately-held biopharmaceutical company. Mr. Papadimitriou holds an MBA from Harvard Business School and a Bachelor of Arts in Computer Science and Business Economics from Brown University.

 **About Cognex**

Cognex Corporation ("the Company" or "Cognex") invents and commercializes technologies that address some of the most critical manufacturing and distribution challenges. We are a leading global provider of machine vision products and solutions that improve efficiency and quality in high-growth-potential businesses across attractive industrial end markets. Our solutions blend physical products and software to capture and analyze visual information, allowing for the automation of manufacturing and distribution tasks for customers worldwide. Machine vision products are used to automate the manufacturing or distribution and tracking of discrete items, such as mobile phones, electric vehicle batteries and e-commerce packages, by locating, identifying, inspecting, and measuring them. Machine vision is important for applications in which human vision is inadequate to meet requirements for size, accuracy, or speed, or in instances where substantial cost savings or quality improvements are maintained.

Cognex is the world's leader in the machine vision industry, having shipped more than 4 million image-based products, representing over $10 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

 *Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words "expects," "anticipates," "estimates," "believes," "projects," "intends," "plans," "will," "may," "shall," "could," "should," and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements—which may include statements regarding business and market trends; future financial performance; growth opportunities; and strategic plans—involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the inability to attract and retain skilled employees and directors and maintain our unique corporate culture; (2) the failure to effectively manage our growth; and (3) the impact of competitive pressures; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2022. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.*

## Contacts
Nathan McCurren <br> Investor Relations <br> Nathan.mccurren@cognex.com